Literature DB >> 31757757

Dynamic Imaging of RNA in Living Cells by CRISPR-Cas13 Systems.

Liang-Zhong Yang1, Yang Wang1, Si-Qi Li1, Run-Wen Yao1, Peng-Fei Luan1, Huang Wu1, Gordon G Carmichael2, Ling-Ling Chen3.   

Abstract

Visualizing the location and dynamics of RNAs in live cells is key to understanding their function. Here, we identify two endonuclease-deficient, single-component programmable RNA-guided and RNA-targeting Cas13 RNases (dCas13s) that allow robust real-time imaging and tracking of RNAs in live cells, even when using single 20- to 27-nt-long guide RNAs. Compared to the aptamer-based MS2-MCP strategy, an optimized dCas13 system is user friendly, does not require genetic manipulation, and achieves comparable RNA-labeling efficiency. We demonstrate that the dCas13 system is capable of labeling NEAT1, SatIII, MUC4, and GCN4 RNAs and allows the study of paraspeckle-associated NEAT1 dynamics. Applying orthogonal dCas13 proteins or combining dCas13 and MS2-MCP allows dual-color imaging of RNAs in single cells. Further combination of dCas13 and dCas9 systems allows simultaneous visualization of genomic DNA and RNA transcripts in living cells.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-dCas13; MUC4; NEAT1; PguCas13b; PspCas13b; RNA dynamics; SatIII; nuclear stress bodies; paraspeckles

Mesh:

Substances:

Year:  2019        PMID: 31757757     DOI: 10.1016/j.molcel.2019.10.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  64 in total

Review 1.  Illuminating RNA Biology: Tools for Imaging RNA in Live Mammalian Cells.

Authors:  Esther Braselmann; Colin Rathbun; Erin M Richards; Amy E Palmer
Journal:  Cell Chem Biol       Date:  2020-07-07       Impact factor: 8.116

2.  RNA-protein interaction mapping via MS2- or Cas13-based APEX targeting.

Authors:  Shuo Han; Boxuan Simen Zhao; Samuel A Myers; Steven A Carr; Chuan He; Alice Y Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

Review 3.  The expanding regulatory mechanisms and cellular functions of circular RNAs.

Authors:  Ling-Ling Chen
Journal:  Nat Rev Mol Cell Biol       Date:  2020-05-04       Impact factor: 94.444

4.  Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing.

Authors:  Sarah Balderston; Gabrielle Clouse; Juan-José Ripoll; Grace K Pratt; Giedrius Gasiunas; Jens-Ole Bock; Eric Paul Bennett; Kiana Aran
Journal:  CRISPR J       Date:  2021-06

5.  Use of circular RNAs as markers of readthrough transcription to identify factors regulating cleavage/polyadenylation events.

Authors:  Dongming Liang; Deirdre C Tatomer; Jeremy E Wilusz
Journal:  Methods       Date:  2021-04-18       Impact factor: 3.608

6.  CBRPP: a new RNA-centric method to study RNA-protein interactions.

Authors:  Yunfei Li; Shengde Liu; Lili Cao; Yujie Luo; Hongqiang Du; Siji Li; Zeming Zhang; Xuefei Guo; Wenmin Tian; Catherine Cl Wong; Fuping You
Journal:  RNA Biol       Date:  2021-02-17       Impact factor: 4.652

Review 7.  Using CRISPR to understand and manipulate gene regulation.

Authors:  Ersin Akinci; Marisa C Hamilton; Benyapa Khowpinitchai; Richard I Sherwood
Journal:  Development       Date:  2021-04-29       Impact factor: 6.868

8.  Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells.

Authors:  Alejandro Méndez-Mancilla; Hans-Hermann Wessels; Mateusz Legut; Anastasia Kadina; Megumu Mabuchi; John Walker; G Brett Robb; Kevin Holden; Neville E Sanjana
Journal:  Cell Chem Biol       Date:  2021-08-02       Impact factor: 8.116

Review 9.  Interrogating lncRNA functions via CRISPR/Cas systems.

Authors:  Meira S Zibitt; Corrine Corrina R Hartford; Ashish Lal
Journal:  RNA Biol       Date:  2021-03-26       Impact factor: 4.652

10.  Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma.

Authors:  Ye Wu; Weili Jin; Qixue Wang; Junhu Zhou; Yunfei Wang; Yanli Tan; Xiaoteng Cui; Fei Tong; Eryan Yang; Jian Wang; Chunsheng Kang
Journal:  Mol Ther       Date:  2021-07-16       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.